NAD+ Supplements Can Raise a Biomarker. That's Not the Same as Slowing Aging.

If you’ve spent any time in wellness or longevity circles lately, you’ve probably heard about NAD+ supplements. They’re marketed as anti-aging breakthroughs, cellular rejuvenation tools, and, in some clinics, as IV drips that promise to restore your energy and turn back the clock. The products aren’t cheap. A month of NMN or NR capsules can run north of fifty dollars, and IV NAD+ infusions cost hundreds per session.

So what’s actually behind the claims? The short answer: the biology is real, but the human evidence for anti-aging isn’t there yet. That gap — between a lab signal and a life-extension promise — is where a lot of money gets made, and it’s what this piece is about.

What NAD+ actually is

NAD stands for nicotinamide adenine dinucleotide. It’s a coenzyme — a helper molecule — that’s involved in hundreds of metabolic reactions in your cells. Your body makes it from B3-family compounds: niacin, nicotinamide, nicotinamide riboside (NR), and nicotinamide mononucleotide (NMN) are all part of that same family tree. NAD is required by more than 400 enzymes, and it plays roles in energy metabolism, DNA repair, and cellular signaling. So yes, it matters. A lot.

Researchers got interested in NAD boosters partly because NAD levels appear to decline with age. That observation, combined with strong results in animal and cell studies, launched the whole NAD+ supplement industry.

And the animal studies do look interesting — I mean genuinely, if you read the rodent papers. Research has shown improvements in metabolic markers, mitochondrial function, and some functional endpoints when NAD pathways are boosted. But — and this is where things get slippery — rodent biology is not human biology, and metabolic improvements in lab animals don’t automatically mean the same supplement will extend your healthspan. Mice live two years. Humans live eighty. The gap between those timelines matters when you’re trying to study aging.

What the human evidence actually shows

Here’s the part where the story gets uneven.

Human trials of oral NR and NMN do show something real: they can raise NAD-related biomarkers in the blood. A 2026 systematic review published in Ageing Research Reviews — the most thorough look at this question to date — confirmed that oral NR and NMN have clear biological activity. Blood NAD metabolites go up. That part of the promise holds.

But raising a biomarker is not the same as producing a clinical benefit. And that’s where the evidence gets thin.

The same 2026 review — a PRISMA-guided analysis of both preclinical and clinical evidence — found that human functional outcomes are inconsistent. Some trials show small endpoint-specific improvements. Many show nothing meaningful. Overall, the review concluded that clinical effectiveness for anti-aging or wellness outcomes remains inconclusive.

Let me walk through what some of the individual trials found, because the details matter more than the headlines.

A randomized, double-blind, placebo-controlled trial of NMN in 80 healthy middle-aged adults — published in GeroScience — found that NMN raised blood NAD/NADH levels and appeared tolerated over 60 days. That sounds promising, and it is. But the trial was short, the study was sponsored by companies connected to the product, and the higher dose tested (900 mg/day) didn’t clearly outperform the lower dose (600 mg/day). That’s not a failure, but it’s also not proof that NMN slows aging.

Another small trial — a crossover study of NR in 24 middle-aged and older adults, published in Nature Communications — found that NR elevated NAD+ metabolism and was tolerated over six weeks. Again: real biological signal, short duration, no evidence of lifespan extension or age reversal.

Then there are the trials where the hoped-for benefit vanished when tested properly — and this is the kind of thing that keeps researchers up at night, or at least keeps the research questions alive. A pilot study in older adults with mild cognitive impairment found that NR raised blood NAD+ and was tolerated, but cognitive outcomes didn’t significantly improve. A pilot randomized trial in people with hypertension found that NR plus exercise was not more effective than exercise alone for daytime blood pressure. There was a post-hoc signal for nighttime blood pressure, but post-hoc findings need confirmation, not celebration.

I’ve watched enough supplement studies go through this cycle to recognize the pattern: press release about an exploratory endpoint that looks good, product landing pages within six months, and the confirmatory trial that was supposed to settle the question still “enrolling” three years later.

These aren’t cherry-picked negative results. They’re the kind of data you get when you move from “this should work based on mechanism” to “does it actually work in humans with real endpoints?” The gap is frustratingly consistent.

The FDA situation (and what it doesn’t mean)

You might have heard that FDA changed its position on NMN in late 2025. That’s true, but it means something narrower than what supplement marketing sometimes implies.

Here’s what happened: FDA had previously taken the position that NMN was excluded from the dietary supplement definition because it was first authorized for investigation as a drug. In late 2025, FDA reconsidered. The agency determined that NMN is not excluded from the dietary supplement definition after reviewing evidence that NMN was marketed in supplements before the drug investigation began.

That’s a regulatory-status decision. It is not FDA approval of NMN as safe or effective for anti-aging. FDA does not approve dietary supplements before they reach the market, and supplements legally cannot claim to diagnose, treat, cure, or prevent disease.

So when you see NMN back on shelves with language about “FDA cleared” or “FDA approved,” that’s misleading. The agency decided NMN can be sold as a supplement. That’s it. The question of whether it actually slows aging in humans is a completely separate question, and it’s one the clinical evidence hasn’t answered.

What about IV NAD+?

Some wellness clinics offer NAD+ intravenously, presenting it as a more direct and powerful approach than oral supplements. The reasoning seems intuitive: bypass the digestive system, get NAD+ straight into the bloodstream.

But the 2026 systematic review found no eligible outcomes trials evaluating IV or IM NAD+ for anti-aging or wellness indications. Zero. The oral precursors — NR and NMN — have at least some human trials, even if they’re small and short. IV NAD+ for anti-aging wellness has essentially no outcomes evidence behind it. That’s a striking gap for a treatment that can cost several hundred dollars per session.

This doesn’t mean IV NAD+ is dangerous (though any IV therapy carries inherent risks that a clinic should discuss with you openly). It means the evidence to support anti-aging claims for IV NAD+ is even thinner than it is for oral supplements.

Safety: what’s known and what isn’t

Oral NR and NMN appear to be generally well tolerated in short-term trials lasting weeks to months. That’s the good news, and it’s genuinely better than finding toxicity signals right out of the gate.

The catch: “well tolerated for a few months” is not the same as “safe for years of daily anti-aging use.” Long-term safety data simply doesn’t exist yet. The trials that exist are too short and too small to detect uncommon or delayed adverse effects.

There are also some specific cautions worth knowing about. The Cleveland Clinic has flagged a theoretical concern that boosting cellular energy pathways could potentially support cancer-cell growth. This isn’t proven — it’s a theoretical risk, not an established danger — but it’s enough of a concern that cancer patients and survivors should discuss NAD+ supplements with their oncologist before using them.

High-dose B3-family compounds aren’t risk-free either. The NIH Office of Dietary Supplements notes that high intakes of nicotinic acid and nicotinamide from supplements or medications can cause adverse effects. High-dose niacin for lipid disorders should only be used under medical supervision. Whether those same concerns apply to NR and NMN at the doses people take for anti-aging is unclear, because the long-term data isn’t there to answer the question.

And a practical note: “NAD+ supplement” can mean several different things. It might contain NAD+ itself, or NR, or NMN, or nicotinamide, or niacin, or a blend with herbs and other ingredients. The evidence, the risks, and the unknowns differ by form. A bottle labeled “NAD+” doesn’t tell you which one you’re getting.

Who should talk to a clinician first

This section matters, so don’t skip it.

If any of the following applies to you, the safe move is to talk with a qualified health professional before using NAD+, NMN, NR, or high-dose B3-family supplements. You’re pregnant, breastfeeding, or trying to conceive — have that conversation. You have a history of cancer or are currently being treated for cancer — the Cleveland Clinic’s theoretical concern about cellular energy pathways and cancer-cell growth makes this one non-negotiable. You have liver disease, kidney disease, or cardiovascular disease. You have any chronic medical condition, really. You take prescription medications — especially blood pressure drugs, diabetes medications, cancer therapies, or anything processed by the liver or kidneys, where interactions are a legitimate unknown. You’re an older adult taking multiple supplements or medications (and honestly, if you’re over 65 and your supplement drawer has more bottles than your fridge has vegetables, that alone is worth reviewing with someone who knows your full med list). And if you’re considering IV NAD+ infusions, you should be asking questions about outcomes evidence, not just comfort and vibes.

This isn’t a “consult your doctor” checkbox at the end of a blog post. The long-term safety gap, the cancer caution, and the medication-interaction risks make this conversation a genuinely important one for a lot of people.

Also: NAD+ supplements should not be used as a substitute for medical care. If you’re managing hypertension, diabetes, cognitive concerns, chronic fatigue, or any age-related condition, these supplements are not treatments. The current evidence does not support using them that way.

Bottom line

The NAD+ story is not a scam. There’s real biology here. NAD is genuinely important, the age-related decline is a legitimate research target, and human studies do show that oral NR and NMN can move NAD-related biomarkers. That’s more than you can say for a lot of supplement categories.

But the gap between “raises a biomarker” and “slows human aging” is enormous. The clinical trials that exist are small, short, and inconsistent in their functional findings. The best available review — published in 2026 — says anti-aging effectiveness is not proven. IV NAD+ has even less evidence behind it. And the long-term safety picture for healthy people taking these compounds daily for years is simply unknown.

None of this means the research isn’t worth following. Larger and longer trials are underway — the NADage study, for instance, is testing NR for frailty and physical function in older adults, and those results will actually matter. But right now, the evidence for anti-aging in humans isn’t there.

If you’re looking for things with stronger real-world grounding than expensive longevity supplements, the list isn’t exciting but it’s honest: regular exercise, adequate sleep, a varied diet, and medical care for conditions that need it. Those approaches have decades of outcomes evidence behind them. NAD+ supplements, for all their biological plausibility, don’t yet.

The lab signal is real. The life-extension promise isn’t proven. Those two things can both be true, and right now, they are.